Qualitek Labs Ltd
Qualitek Labs Ltd (QLL) last reported results for the quarter ended Mar 2026, with sales of ₹70 crore and net profit of ₹10 crore. The next scheduled event is an EGM on 16 Oct 2026. The stock last traded at ₹566, a market capitalisation of ₹660 crore, on a P/E of 48.0. Over the past 52 weeks the stock has ranged between ₹259 and ₹650. Figures are as of 6 Oct 2026 and are not real time.
Qualitek Labs Ltd share price and key metrics
- Current price
- ₹566
- Market cap
- ₹660 cr
- Stock P/E
- 48.0
- Book value
- ₹131
- ROE
- 11.5%
- ROCE
- 12.1%
- Dividend yield
- 0.00%
- 52w high / low
- 650/259
Metrics as of 6 Oct 2026. Not real time.
Track Qualitek Labs Ltd
Cruxal reads every Qualitek Labs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Qualitek Labs Ltd growth and returns
- 10 Years
- %
- 5 Years
- 81%
- 3 Years
- %
- TTM
- 77%
- 10 Years
- %
- 5 Years
- 144%
- 3 Years
- %
- TTM
- 118%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 46%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- 11%
Qualitek Labs Ltd quarterly results
| ₹ crore | Sep 2025 | Mar 2026 |
|---|---|---|
| Sales | 54 | 70 |
| Expenses | 43 | 52 |
| Operating profit | 11 | 18 |
| OPM % | 21% | 26% |
| Other income | 0 | 0 |
| Interest | 2 | 3 |
| Depreciation | 3 | 4 |
| Profit before tax | 6 | 12 |
| Tax % | 26% | 17% |
| Net profit | 5 | 10 |
| EPS (₹) | 4.09 | 8.44 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Qualitek Labs Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 6 | 12 | 70 | 125 |
| Operating profit | 1 | 1 | 16 | 30 |
| OPM % | 11% | 10% | 23% | 24% |
| Net profit | 0 | 0 | 8 | 15 |
| EPS (₹) | 160.00 | 9.13 | 6.31 | 11.69 |
TTM is the trailing twelve months to the most recent quarter.
Qualitek Labs Ltd balance sheet
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | 0.01 | 0.46 | 10 | 12 |
| Reserves | -1 | 0 | 77 | 141 |
| Borrowings | 11 | 17 | 50 | 94 |
| Other liabilities | 4 | 3 | 21 | 25 |
| Total liabilities | 14 | 21 | 158 | 271 |
| Fixed assets | 6 | 8 | 92 | 152 |
| CWIP | 4 | 4 | 16 | 46 |
| Investments | 0 | 0 | 0 | 0 |
| Other assets | 4 | 9 | 50 | 73 |
| Total assets | 14 | 21 | 158 | 271 |
As reported by the company. Total assets equal total liabilities by construction.
Qualitek Labs Ltd cash flow
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from operations | 1 | -5 | 10 | 14 |
| Cash from investing | -6 | -2 | -60 | -50 |
| Cash from financing | 5 | 7 | 54 | 37 |
| Net cash flow | 0 | -0 | 4 | 1 |
| Free cash flow | -5 | -7 | -13 | -31 |
| CFO / operating profit | 244% | -363% | 75% | 63% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Qualitek Labs Ltd operating ratios
| Per year | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROCE % | — | 6% | — | 12% |
| Debtor days | 69 | 67 | 150 | 124 |
| Cash conversion cycle | 69 | 67 | 150 | 124 |
| Working capital days | -701 | -432 | 25 | -10 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Qualitek Labs Ltd shareholding pattern
Promoters held 56.46% at Mar 2026, down from 73.35% at Mar 2024. FIIs 1.60% and DIIs 0.10%.
| % held | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 73.35% | 73.35% | 54.19% | 54.19% | 56.46% |
| FIIs | 0.00% | 0.00% | 1.77% | 1.77% | 1.60% |
| DIIs | 0.00% | 0.02% | 0.26% | 0.15% | 0.10% |
| Public | 26.65% | 26.62% | 43.79% | 43.90% | 41.84% |
| No. of shareholders | 646 | 632 | 750 | 873 | 876 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Qualitek Labs Ltd events
The next scheduled event is an EGM on 16 Oct 2026.
- EGMApproval for preferential issue of equity shares and fully convertible warrants
- Preferential issueEGM to approve preferential issue of equity shares and warrants
See the full results calendar for every Indian company reporting in the next 30 days.
Qualitek Labs Ltd corporate filings
- Compliance Certificate Under Reg. 74(5) of SEBI (DP) Regulations, 2018-September 2026Company Updatelow impact
- Closure of Trading WindowInsider Trading / SASTlow impact
Cruxal's analysis: As per the attached information
Read the full analysis - Qualitek Labs Limited Announces Successful Conclusion of 8th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Qualitek Labs Limited has successfully concluded its 8th Annual General Meeting held on…
Read the full analysis - Qualitek Labs Limited concludes 8th Annual General Meeting; shareholders approve re-appointment of MD & CEOAGM/EGMlow impact
Cruxal's analysis: Qualitek Labs Limited has successfully concluded its 8th Annual General Meeting held on…
Read the full analysis - Qualitek Labs Ltd announces EGM scheduled for October 16, 2026Company Updatelow impact
Cruxal's analysis: Qualitek Labs Limited has published a newspaper notice regarding the dispatch of the…
Read the full analysis - Qualitek Labs Limited Announces Preferential Issue of Equity Shares and Convertible Warrants to Raise INR 46.98 CroreAGM/EGMhigh impact
Cruxal's analysis: Qualitek Labs Limited has announced a preferential issue of 3.86 lakh equity shares and…
Read the full analysis - Qualitek Labs Limited Announces Substitution of Allottee in Ongoing Preferential IssueCompany Updatelow impact
Cruxal's analysis: Qualitek Labs Limited has notified the exchange regarding a minor administrative change…
Read the full analysis - Qualitek Labs Limited Announces Preferential Issue of Equity Shares and Warrants Aggregating to 46.98 croreCompany Updatehigh impact
Cruxal's analysis: Qualitek Labs Limited has approved a preferential issue of 3.86 lakh equity shares and…
Read the full analysis - Qualitek Labs Limited announces board meeting to consider fund-raising proposalBoard Meetingmedium impact
Cruxal's analysis: Qualitek Labs Limited has scheduled a board meeting for September 22, 2026, to evaluate…
Read the full analysis - Qualitek Labs Limited withdraws proposal to increase managerial remuneration limitAGM/EGMlow impact
Cruxal's analysis: Qualitek Labs Limited has announced the withdrawal of Item No. 4 from its upcoming Eighth…
Read the full analysis - Qualitek Labs Limited announces 8th Annual General Meeting (AGM) scheduled for September 25, 2026Company Updatelow impact
Cruxal's analysis: Qualitek Labs Limited has issued a formal notice for its 8th Annual General Meeting to be…
Read the full analysis - Qualitek Labs Ltd releases FY 2025-26 Annual Report and schedules 8th AGM for September 25, 2026Otherslow impact
Cruxal's analysis: Qualitek Labs has filed its Integrated Annual Report for the financial year 2025-26 and…
Read the full analysis - Qualitek Labs Limited Announces 8th AGM and Reports Strong FY26 Financial PerformanceAGM/EGMhigh impact
Cruxal's analysis: Qualitek Labs Limited has scheduled its 8th Annual General Meeting for September 25…
Read the full analysis - Qualitek Labs Limited schedules 8th Annual General Meeting for 25th September 2026AGM/EGMlow impact
Cruxal's analysis: Qualitek Labs Limited has formally announced the scheduling of its 8th Annual General…
Read the full analysis - Qualitek Labs Limited Announces 8th AGM and Proposes Increase in Managerial Remuneration LimitsOtherslow impact
Cruxal's analysis: Qualitek Labs Limited has scheduled its 8th Annual General Meeting for September 25…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.